IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino acid recombinant IGF-1 analogue featuring an Arg3 substitution and 13-residue N-terminal extension that dramatically reduces IGFBP sequestration in cell-culture proliferation models.
Scientific Profile & Research Key Points: IGF-1 LR3
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino acid recombinant IGF-1 analogue featuring an Arg3 substitution and 13-residue N-terminal extension that dramatically reduces IGFBP sequestration in cell-culture proliferation models.
Active Batch Release Specifications (Lot SL-2026-134)
Analytical release verification for current IGF-1 LR3 (1 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-134 | 2026-10-28 | SEC-HPLC + SDS-PAGE (Reducing & Non-Reducing) | ≥99.0% (Monomeric Purity) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Pre-dissolve in sterile 0.6% (10 mM) Acetic Acid (0.5–1.0 mL), then dilute with buffered carrier solution
Temperature & Stability
Store lyophilized at -20°C; store acidic stock aliquots at -20°C or 2°C–8°C (avoid neutral water alone).
IGF-1 LR3 — Technical Questions & Answers
Why is IGF-1 LR3 analyzed by SEC-HPLC and SDS-PAGE instead of standard small-peptide RP-HPLC alone?
At 9111.50 g/mol, recombinant proteins like IGF-1 LR3 possess tertiary and quaternary folding structures that denature under harsh reversed-phase organic gradients. Size-exclusion chromatography (SEC-HPLC) and SDS-PAGE verify monomeric integrity and detect dimers or aggregates.
How do researchers minimize adsorption and aggregation when preparing IGF-1 LR3 (1 mg)?
Avoid vigorous vortexing, foaming, or repeated freeze-thaw cycles. Slowly introduce buffer along the borosilicate vial wall and consider low-protein-binding polypropylene tubes (or carrier protein buffer where assay-compatible) for nanomolar working dilutions.
What biological receptor system is IGF-1 LR3 used to probe in vitro?
IGF-1 LR3 (CAS 946870-92-4) targets Insulin-like Growth Factor 1 Receptor (IGF-1R) with reduced IGFBP binding (Lyophilized sterile acetate/HCl cake). Reference publication: Francis G.L. et al., J Mol Endocrinol (1992) — LR3-IGF-1 reduced IGFBP affinity and enhanced cellular potency (PMID: 1378283).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
CJC-1295, Ipamorelin, and Sermorelin: GHRH Analogues vs Ghrelin Receptor Agonists
A deep dive into somatotropic axis stimulation. Comparing GHRH receptor binding, DAC modification kinetics, ghrelin/GHS-R1a agonism, and pulsatile growth hormone secretion.
Gonadorelin, HCG, HMG and Kisspeptin: Mapping the Hypothalamic-Pituitary-Gonadal Axis
A comparative map of the HPG axis: GnRH receptor agonism (Gonadorelin), LH receptor mimetics (HCG), combined FSH/LH activity (HMG), and upstream GPR54 activation (Kisspeptin-10).
Human Growth Hormone (191aa): Somatropin Structure, Isoforms, and SEC-HPLC Analysis
A deep analysis of authentic 191-amino acid Somatropin vs 192-amino acid Somatrem. Size-exclusion chromatography (SEC), deamidation artifacts, and mass confirmation.
Related GH Secretagogues & Growth Factors Compounds
View category →